Benzinga FDA Puts Cassava's Simufilam Epilepsy Trial On Full Clinical Hold
Cassava Sciences confirms an FDA clinical hold on its simufilam epilepsy trial, delaying plans and requiring more data despite strong cash reserves. read more
Cassava Sciences confirms an FDA clinical hold on its simufilam epilepsy trial, delaying plans and requiring more data despite strong cash reserves. read more